These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 20089096

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Thermal ablation vs surgery for localized kidney cancer: a Surveillance, Epidemiology, and End Results (SEER) database analysis.
    Choueiri TK, Schutz FA, Hevelone ND, Nguyen PL, Lipsitz SR, Williams SB, Silverman SG, Hu JC.
    Urology; 2011 Jul; 78(1):93-8. PubMed ID: 21550636
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A non-cancer-related survival benefit is associated with partial nephrectomy.
    Sun M, Trinh QD, Bianchi M, Hansen J, Hanna N, Abdollah F, Shariat SF, Briganti A, Montorsi F, Perrotte P, Karakiewicz PI.
    Eur Urol; 2012 Apr; 61(4):725-31. PubMed ID: 22172373
    [Abstract] [Full Text] [Related]

  • 6. Compared with radical nephrectomy, nephron-sparing surgery offers a long-term survival advantage in patients between the ages of 20 and 44 years with renal cell carcinomas (≤4 cm): an analysis of the SEER database.
    Daugherty M, Bratslavsky G.
    Urol Oncol; 2014 Jul; 32(5):549-54. PubMed ID: 24495447
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. How often are patients with diabetes or hypertension being treated with partial nephrectomy for renal cell carcinoma? A population-based analysis.
    Abouassaly R, Finelli A, Tomlinson GA, Urbach DR, Alibhai SM.
    BJU Int; 2011 Dec; 108(11):1806-12. PubMed ID: 21599823
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Radical versus partial nephrectomy: effect on overall and noncancer mortality.
    Zini L, Perrotte P, Capitanio U, Jeldres C, Shariat SF, Antebi E, Saad F, Patard JJ, Montorsi F, Karakiewicz PI.
    Cancer; 2009 Apr 01; 115(7):1465-71. PubMed ID: 19195042
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cytoreductive partial nephrectomy does not undermine cancer control in metastatic renal cell carcinoma: a population-based study.
    Capitanio U, Zini L, Perrotte P, Shariat SF, Jeldres C, Arjane P, Pharand D, Widmer H, Péloquin F, Montorsi F, Patard JJ, Karakiewicz PI.
    Urology; 2008 Nov 01; 72(5):1090-5. PubMed ID: 18799207
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Baseline renal function, ischaemia time and blood loss predict the rate of renal failure after partial nephrectomy.
    Jeldres C, Bensalah K, Capitanio U, Zini L, Perrotte P, Suardi N, Tostain J, Valeri A, Descotes JL, Rambeaud JJ, de La Taille A, Salomon L, Abbou C, Patard JJ, Karakiewicz PI.
    BJU Int; 2009 Jun 01; 103(12):1632-5. PubMed ID: 19545272
    [Abstract] [Full Text] [Related]

  • 17. The true risk of blood transfusion after nephrectomy for renal masses: a population-based study.
    Vricella GJ, Finelli A, Alibhai SM, Ponsky LE, Abouassaly R.
    BJU Int; 2013 Jun 01; 111(8):1294-300. PubMed ID: 23368715
    [Abstract] [Full Text] [Related]

  • 18. Tumour size, tumour complexity, and surgical approach are associated with nephrectomy type in small renal cortical tumours treated electively.
    Broughton GJ, Clark PE, Barocas DA, Cookson MS, Smith JA, Herrell SD, Chang SS.
    BJU Int; 2012 Jun 01; 109(11):1607-13. PubMed ID: 21939493
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.